Miller Capital Partners, Inc.
Source: SEC Form 13F · as of Mar 2026Miller Capital Partners, Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $7.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$7.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 3,878 | $3.6M |
| ABBVAbbVie Inc. | 5,345 | $1.2M |
| JNJJOHNSON & JOHNSON | 4,129 | $1.0M |
| ABTABBOTT LABORATORIES | 6,887 | $707K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 505 | $226K |
| AMGNAMGEN INC | 530 | $186K |
| ELVElevance Health Inc. | 453 | $133K |
| PMPhilip Morris International Inc | 755 | $125K |
| BMYBRISTOL MYERS SQUIBB CO | 1,435 | $87K |
| MRKMerck & Co., Inc. | 425 | $51K |
| SABSSAB BIOTHERAPEUTICS, INC. | 12,870 | $49K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 160 | $43K |
| GEHCGE HealthCare Technologies Inc. | 387 | $28K |
| CORCencora Inc. | 30 | $9K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.